This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2007 Sep;4(5):1209-13.

doi: 10.1111/j.1743-6109.2007.00581.x.

The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman

Sidney Glina¹, Martin K Gelbard, Emre Akkus, Gerald H Jordan, Laurence A Levine

Affiliations

PMID: 17727345
DOI: 10.1111/j.1743-6109.2007.00581.x

The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman

Sidney Glina et al. J Sex Med. 2007 Sep.

. 2007 Sep;4(5):1209-13.

doi: 10.1111/j.1743-6109.2007.00581.x.

Authors

Sidney Glina¹, Martin K Gelbard, Emre Akkus, Gerald H Jordan, Laurence A Levine

Affiliation

¹ Department of Urology, Instituto H. Ellis, São Paulo, Brazil. glinas@terra.com.br

PMID: 17727345
DOI: 10.1111/j.1743-6109.2007.00581.x

No abstract available

PubMed Disclaimer

Similar articles

[Collagenase clostridium histolyticum for Peyronie's disease: A new minimally invasive and effective treatment].
Lin HC, Zhang HT, Jiang H. Lin HC, et al. Zhonghua Nan Ke Xue. 2017 Sep;23(9):771-775. Zhonghua Nan Ke Xue. 2017. PMID: 29726655 Review. Chinese.
Impact of treatment-related adverse events on efficacy of intralesional collagenase therapy for Peyronie's disease.
Walker DT, Shahinyan RH, Amighi A, Regets KV, Mills JN, Eleswarapu SV. Walker DT, et al. Int J Impot Res. 2021 Jan;33(1):128-130. doi: 10.1038/s41443-020-0311-z. Epub 2020 May 26. Int J Impot Res. 2021. PMID: 32457499 No abstract available.
Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
Inal T, Tokatli Z, Akand M, Ozdiler E, Yaman O. Inal T, et al. Urology. 2006 May;67(5):1038-42. doi: 10.1016/j.urology.2005.11.005. Epub 2006 Apr 11. Urology. 2006. PMID: 16581113 Clinical Trial.
Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study.
Gelbard MK, James K, Riach P, Dorey F. Gelbard MK, et al. J Urol. 1993 Jan;149(1):56-8. doi: 10.1016/s0022-5347(17)35998-0. J Urol. 1993. PMID: 8417217 Clinical Trial.
Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol.
Abdel Raheem A, Johnson M, Abdel-Raheem T, Capece M, Ralph D. Abdel Raheem A, et al. Sex Med Rev. 2017 Oct;5(4):529-535. doi: 10.1016/j.sxmr.2017.07.005. Epub 2017 Sep 2. Sex Med Rev. 2017. PMID: 28874327 Review.

See all similar articles

Cited by

Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease: A 'Real World' Clinical Perspective.
Anaissie J, Hellstrom WJ, Yafi FA. Anaissie J, et al. Drugs. 2016 Oct;76(16):1523-1528. doi: 10.1007/s40265-016-0649-1. Drugs. 2016. PMID: 27770352
Intralesional collagenase in the treatment of Peyronie's disease.
Honig SC. Honig SC. Ther Adv Urol. 2014 Apr;6(2):47-53. doi: 10.1177/1756287213509849. Ther Adv Urol. 2014. PMID: 24688600 Free PMC article. Review.
Non-surgical therapies for Peyronie's disease.
Rosenberg JE, Ergun O, Hwang EC, Risk MC, Jung JH, Edwards ME, Blair Y, Dahm P. Rosenberg JE, et al. Cochrane Database Syst Rev. 2023 Jul 17;7(7):CD012206. doi: 10.1002/14651858.CD012206.pub2. Cochrane Database Syst Rev. 2023. PMID: 37490423 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources